Bioengineered skin consists of the outer epidermis and/or dermis (the layer of skin between the epidermis and subcutaneous tissue) embedded in an acellular matrix (supporting structure) to form a biological skin substitute. Products are made from a variety of sources, including human tissue (from patients or others), non-human tissue (bovine, porcine, horse), synthetic materials (man-made), or a combination of these materials. This report contains market size and forecasts of Bioengineered Skin Substitutes in Global, including the following market information: Global Bioengineered Skin Substitutes Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Bioengineered Skin Substitutes market was valued at 1507.6 million in 2021 and is projected to reach US$ 3190.3 million by 2028, at a CAGR of 11.3% during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. Allogeneic Acellular Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Bioengineered Skin Substitutes include Allergan (AbbVie), AlloSource, Organogenesis, BD, Smith & Nephew, Integra LifeSciences, Synthes (Johnson & Johnson), Axogen and Vericel Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bioengineered Skin Substitutes companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Bioengineered Skin Substitutes Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Bioengineered Skin Substitutes Market Segment Percentages, by Type, 2021 (%) Allogeneic Acellular Xenogeneic Allogeneic Cells Autologous Global Bioengineered Skin Substitutes Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Bioengineered Skin Substitutes Market Segment Percentages, by Application, 2021 (%) Hospitals Specialty Clinics Wound Care Centers Global Bioengineered Skin Substitutes Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Bioengineered Skin Substitutes Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Bioengineered Skin Substitutes revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Bioengineered Skin Substitutes revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Allergan (AbbVie) AlloSource Organogenesis BD Smith & Nephew Integra LifeSciences Synthes (Johnson & Johnson) Axogen Vericel Corporation LifeNet Health MTF Biologics Arthrex Wright Medical Group NV (Stryker) Cook Biotech Incorporated Aroa Biosurgery Surgalign Holdings Anika Therapeutics Forticell Bioscience MLM Biologics Promethean LifeSciences
1 Introduction to Research & Analysis Reports 1.1 Bioengineered Skin Substitutes Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Bioengineered Skin Substitutes Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research
